Clinical Trial Update: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting results for Bonviva (ibandronate) in women with postmenopausal osteoporosis who were previously treated with Bonviva.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Bonviva (ibandronic acid)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Post-Menopausal Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2009-07-21